Kromatel – Advanced Hypertension Management

Preferred ARB in Hypertensive patients with obesity/overweight, metabolic syndrome, or glucose intolerance. 85% dissolution in 30 min is considered rapidly dissolving drug. Preferred ARB in Hypertensive patients with
obesity/overweight
metabolic syndrome
glucose intolerance
An effective healthcare system requires a well-trained workforce, adequate funding, reliable information, and well-maintained facilities

Kromatel-AM : When Monotherapy is not enough

Telmisartan 40 mg + Amlodipine 5 mg; Ideal for patients requiring combination therapy.It Controls and stabilizes blood pressure Results in greater BP reduction, higher DBP & SBP goal and response rates as compared to monotherapy. Safe & efficacious option for the long-term treatment of hypertension and offer advantage on endothelial function. Achieves tight BP control due to strong efficacy and long half-life of each agent. Indicated In:
Hypertension
Angina Pectoris
Myocardial Infarction
Coronary Heart Disease

Kromatel-H : In Stage II hypertension

Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg; Designed for advanced hypertension control.Clinical Advantages:
Significant reduction in risk of Ischemic Heart Disease & Stroke
Superior reduction in SBP and DBP
Added diuretic effect lowers peripheral resistance
Proven benefits in diabetic hypertensive patients